MedPath

XYDALBA 500 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

XYDALBA 500 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

114986001

Prescription Type

Uso Hospitalario

Authorization Date

Jun 26, 2015

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number114986001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

DALBAVANCINAActive
Quantity: 516 mg
Name: DALBAVANCINA

ATC CLASSIFICATION (2)

J01XA
J01XA04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.